Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Scherer

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
Molecular and Cellular Biology|May 1, 1995
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activationJ A Brockman, D C Scherer, T A McKinsey, et al.
Journal of Voice : Official Journal of the Voice Foundation|December 1, 1994
The integration of voice science, voice pathology, medicine, public speaking, acting, and singingR C Scherer, D W Brewer, R Colton, et al.
Nature|April 30, 2003
A role for Wnt signalling in self-renewal of haematopoietic stem cellsTannishtha Reya, Andrew W Duncan, Laurie Ailles, et al.
Veterinary Microbiology|December 26, 2001
Latent infection by bovine herpesvirus type-5 in experimentally infected rabbits: virus reactivation, shedding and recrudescence of neurological diseaseL Caron, E F Flores, R Weiblen, et al.
Journal of the American Geriatrics Society|October 16, 1999
Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostelM S Stein, J D Wark, S C Scherer, et al.
Annual Review of Immunology|March 5, 2003
Biology of hematopoietic stem cells and progenitors: implications for clinical applicationMotonari Kondo, Amy J Wagers, Markus G Manz, et al.
Frontiers in Pharmacology|November 2, 2017
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy VolunteersDavid Monteith, Emily C Collins, Corinne Vandermeulen, et al.
Diabetes Care|March 22, 2013
Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetesJoanne Sloan-Lancaster, Eyas Abu-Raddad, John Polzer, et al.
Nature Reviews. Drug Discovery|December 16, 2014
A decade of innovation in pharmaceutical R&D: the Chorus modelPaul K Owens, Eyas Raddad, Jeffrey W Miller, et al.
Neurology|February 22, 2008
Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophyC Verny, D Loiseau, C Scherer, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
Molecular and Cellular Biology|May 1, 1995
Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activationJ A Brockman, D C Scherer, T A McKinsey, et al.
Journal of Voice : Official Journal of the Voice Foundation|December 1, 1994
The integration of voice science, voice pathology, medicine, public speaking, acting, and singingR C Scherer, D W Brewer, R Colton, et al.
Nature|April 30, 2003
A role for Wnt signalling in self-renewal of haematopoietic stem cellsTannishtha Reya, Andrew W Duncan, Laurie Ailles, et al.
Veterinary Microbiology|December 26, 2001
Latent infection by bovine herpesvirus type-5 in experimentally infected rabbits: virus reactivation, shedding and recrudescence of neurological diseaseL Caron, E F Flores, R Weiblen, et al.
Journal of the American Geriatrics Society|October 16, 1999
Falls relate to vitamin D and parathyroid hormone in an Australian nursing home and hostelM S Stein, J D Wark, S C Scherer, et al.
Annual Review of Immunology|March 5, 2003
Biology of hematopoietic stem cells and progenitors: implications for clinical applicationMotonari Kondo, Amy J Wagers, Markus G Manz, et al.
Frontiers in Pharmacology|November 2, 2017
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy VolunteersDavid Monteith, Emily C Collins, Corinne Vandermeulen, et al.
Diabetes Care|March 22, 2013
Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetesJoanne Sloan-Lancaster, Eyas Abu-Raddad, John Polzer, et al.
Nature Reviews. Drug Discovery|December 16, 2014
A decade of innovation in pharmaceutical R&D: the Chorus modelPaul K Owens, Eyas Raddad, Jeffrey W Miller, et al.
Neurology|February 22, 2008
Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophyC Verny, D Loiseau, C Scherer, et al.
Pageof 19